Skip to content
lifestyle.celebhomes.net
Author:
argenx SE
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
May 8, 2026
argenx Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
argenx to Present at BofA Securities 2026 Health Care Conference
May 6, 2026
argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer
May 6, 2026
←
Previous Page
1
2
3